Full-Time

Executive Assistant

Confirmed live in the last 24 hours

Vaxcyte

Vaxcyte

201-500 employees

Develops vaccines for bacterial infections

Biotechnology
Healthcare

Compensation Overview

$132k - $145kAnnually

+ Equity Component

Expert

San Carlos, CA, USA

Requires onsite presence in San Carlos, California for three days a week.

Category
Executive Support
Administrative & Executive Assistance
Required Skills
PowerPoint/Keynote/Slides
Requirements
  • Bachelor's degree with a minimum of 10 years’ experience supporting executive level leaders, preferably in the Biotech or Life Science field.
  • Exceptional organizational skills that reflect ability to perform and prioritize multiple tasks seamlessly with attention to detail.
  • Strong interpersonal skills and the ability to build relationships. Demonstrates emotional maturity and a track record of developing strong credibility and trust with all levels within the organization.
  • Exceptional communication skills, both written and verbal.
  • Proven project management skills with experience driving internal and external events and business deliverables.
  • Solutions-oriented individual who can detect problems early and actively seeks opportunities and proposes creative and practical solutions.
  • Resourceful with ability to be effective working independently or as part of a project team.
  • Proven ability to handle confidential information with discretion and discernment and demonstrate the highest level of customer/client service and response.
  • Demonstrated ability to achieve high-performance goals and meet deadlines while managing changing or competing demands. Thrives in a fast-paced, growing organization.
  • Proficient in Microsoft Office (Outlook, Word, Excel, and PowerPoint), Zoom.
  • Ability to work onsite 3 days a week required.
Responsibilities
  • Be the executive’s force multiplier.
  • Optimize and ensure their preparation and effectiveness.
  • Anticipate and manage meeting, travel, and other logistical demands.
  • Proactively and strategically manage their calendar ensuring schedules match with the executive’s priorities.
  • Understand and help prioritize key strategic initiatives and tasks.
  • Represent Vaxcyte to several external constituents.
  • Attend important meetings, compose meeting materials, take notes, and manage follow-up.
  • Organize and execute team functions such as team building, and offsite events as requested.
  • Provide support to the legal team by organizing team events, assisting with team projects.
  • Assist General Counsel with managing team priorities and keeping track of assignments, projects and timelines.
  • Build cross-functional relationships at all levels of the Company to ensure understanding of the business, leaders and workflow.
  • Collaborate and partner closely with other EAs regarding company-wide activities, cross-functional meetings, etc.
  • Engage in company-wide culture team activities, including logistical support.
  • Develop an understanding of the team and field requests from all contacts, making a point to be available and approachable.
  • Provide ad-hoc support as requested to individuals across the executives’ teams.
  • Demonstrate composure and flexibility, regardless of competing priorities.
  • Find new and efficient ways to create work processes to help maximize your executives' time, such as weekly reporting, goal-tracking, tracking team travel arrangements, and team meetings.
  • Manage, and assist them in managing, teams across multiple domestic and international time zones.

Vaxcyte develops vaccines aimed at preventing bacterial infections, focusing on diseases like invasive pneumococcal disease, Group A Strep, periodontitis, and Shigella. Their lead product, VAX-24, is a pneumococcal conjugate vaccine that targets 24 strains of the Streptococcus pneumoniae bacteria and has received Breakthrough Therapy designation from the FDA. Vaxcyte utilizes advanced chemistry and a proprietary cell-free protein synthesis platform, XpressCF™, to create vaccines that can effectively address the complex defenses of bacteria while stimulating an immune response. This method sets them apart from traditional cell-based vaccine production. The company's goal is to develop broad-spectrum vaccines that can significantly reduce the impact of bacterial diseases on global health.

Company Stage

IPO

Total Funding

$273.3M

Headquarters

Foster City, California

Founded

2013

Growth & Insights
Headcount

6 month growth

24%

1 year growth

63%

2 year growth

137%
Simplify Jobs

Simplify's Take

What believers are saying

  • Vaxcyte's VAX-24 has FDA Breakthrough Therapy designation for pneumococcal disease prevention.
  • Recent $1.5 billion public offering boosts Vaxcyte's financial resources for development.
  • Growing demand for pneumococcal vaccines in emerging markets supports Vaxcyte's growth.

What critics are saying

  • Competition from mRNA vaccine developers like Moderna and BioNTech is intense.
  • Potential delays in clinical trials could impact vaccine approval timelines.
  • High vaccine development costs may strain Vaxcyte's financial resources.

What makes Vaxcyte unique

  • Vaxcyte uses a proprietary cell-free protein synthesis platform for vaccine development.
  • Their lead product, VAX-24, targets 24 strains of Streptococcus pneumoniae.
  • Vaxcyte's vaccines aim to combat bacterial infections like pneumococcal disease and Group A Strep.

Help us improve and share your feedback! Did you find this helpful?